TA-CIN Vaccine With Anti-PD-1 Therapy in Recurrent HPV16-associated Cancers
Clinical trial NCT05132803 · WITHDRAWN
Trial details
- NCT number
- NCT05132803
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2022-01-18
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.